Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Lung Cancer

  Free Subscription


20.01.2020

1 AJR Am J Roentgenol
6 Ann Thorac Surg
1 Arch Bronconeumol
1 Arch Pathol Lab Med
3 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
2 Cancer Sci
1 Clin Cancer Res
2 Clin Lung Cancer
2 Int J Cancer
3 Int J Oncol
1 J Clin Invest
6 J Thorac Cardiovasc Surg
6 J Thorac Oncol
2 JAMA Oncol
7 Lung Cancer
1 Oncogene
1 Oncologist
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. COLLETTI PM
    Earlier Diagnosis of Subcentimeter Lung Cancers Is Not Self-Evidently Beneficial: Personal Experience.
    AJR Am J Roentgenol. 2019;213:819-820.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. ARGEMI X, Santelmo N, Matau C, Croce S, et al
    Cystic Lung Lesions Mimicking Hydatidosis: Hamartoma or Benign Metastazing Leiomyoma?
    Ann Thorac Surg. 2019;108:e195-e198.
    PubMed     Text format     Abstract available

  3. ESPINOZA-MERCADO F, Borgella JD, Berz D, Alban RF, et al
    Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Ann Thorac Surg. 2019;108:889-896.
    PubMed     Text format     Abstract available

  4. SUN W, Zhang L, Wang L, Ren Y, et al
    Three-Dimensionally Printed Template for Percutaneous Localization of Multiple Lung Nodules.
    Ann Thorac Surg. 2019;108:883-888.
    PubMed     Text format     Abstract available

  5. WANG Y, Cai S, Gao S, Xue Q, et al
    Tracheobronchial Adenoid Cystic Carcinoma: 50-Year Experience at the National Cancer Center, China.
    Ann Thorac Surg. 2019;108:873-882.
    PubMed     Text format     Abstract available

  6. CATTONI M, Vallieres E, Brown LM, Sarkeshik AA, et al
    Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung.
    Ann Thorac Surg. 2019;108:859-865.
    PubMed     Text format     Abstract available

  7. GALETTA D, Rampinelli C, Funicelli L, Casiraghi M, et al
    CT-Guided Percutaneous Radiotracer Localization and Resection of Indistinct/Small Pulmonary Lesions.
    Ann Thorac Surg. 2019 May 7. pii: S0003-4975(19)30624.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  8. VARELA RECIO J, Camacho Marente V, Trivino Ramirez A, Espinosa Jimenez D, et al
    Small Bowel Perforation Due to Metastatic Pleomorphic Lung Cancer.
    Arch Bronconeumol. 2020 Jan 10. pii: S0300-2896(19)30577.
    PubMed     Text format    


    Arch Pathol Lab Med

  9. LAYFIELD LJ, Hammer RD, White SK, Furtado LV, et al
    Molecular Testing Strategies for Pulmonary Adenocarcinoma: An Optimal Approach With Cost Analysis.
    Arch Pathol Lab Med. 2019;143:628-633.
    PubMed     Text format     Abstract available


    Cancer

  10. WEISS JM, Pennell N, Deal AM, Morgenzstern D, et al
    Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy.
    Cancer. 2020 Jan 14. doi: 10.1002/cncr.32573.
    PubMed     Text format     Abstract available

  11. YOUN B, Trikalinos NA, Mor V, Wilson IB, et al
    Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer.
    Cancer. 2020 Jan 14. doi: 10.1002/cncr.32624.
    PubMed     Text format     Abstract available

  12. AGGARWAL C, Langer CJ
    Systemic therapy for elderly patients with non-small cell lung cancer: Where do we stand in 2019?
    Cancer. 2020 Jan 14. doi: 10.1002/cncr.32625.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  13. ZHOU H, Liu J, Zhang Y, Zhang L, et al
    Inflammatory bowel disease associated with the combination treatment of nivolumab and metformin: data from the FDA adverse event reporting system.
    Cancer Chemother Pharmacol. 2019;83:599-601.
    PubMed     Text format     Abstract available


    Cancer Lett

  14. YU JJ, Zhou DD, Cui B, Zhang C, et al
    Disruption of the EGFR-SQSTM1 Interaction by a Stapled Peptide Suppresses Lung Cancer via Activating Autophagy and Inhibiting EGFR Signaling.
    Cancer Lett. 2020 Jan 10. pii: S0304-3835(20)30012.
    PubMed     Text format     Abstract available


    Cancer Sci

  15. SUGIMORI M, Sugimori K, Tsuchiya H, Suzuki Y, et al
    Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
    Cancer Sci. 2020;111:266-278.
    PubMed     Text format     Abstract available

  16. HUANG T, Zhou X, Mao X, Yu C, et al
    Lactate-fueled oxidative metabolism drives DNA methyltransferase 1-mediated transcriptional co-activator with PDZ binding domain protein activation.
    Cancer Sci. 2020;111:186-199.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  17. ISOMOTO K, Haratani K, Hayashi H, Shimizu S, et al
    Impact of EGFR-TKI treatment on the tumor immune microenvironment in EGFR mutation-positive non-small cell lung cancer.
    Clin Cancer Res. 2020 Jan 14. pii: 1078-0432.CCR-19-2027.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  18. CHAN ST, Ruan D, Shaverdian N, Raghavan G, et al
    Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
    Clin Lung Cancer. 2019 Oct 21. pii: S1525-7304(19)30284.
    PubMed     Text format     Abstract available

  19. KARACZ CM, Yan J, Zhu H, Gerber DE, et al
    Timing, Sites, and Correlates of Lung Cancer Recurrence.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30344.
    PubMed     Text format     Abstract available


    Int J Cancer

  20. GRUNEWALD S, Politz O, Bender S, Heroult M, et al
    Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.
    Int J Cancer. 2019;145:1346-1357.
    PubMed     Text format     Abstract available

  21. LOPEZ-PLANA A, Fernandez-Nogueira P, Munoz-Guardiola P, Sole-Sanchez S, et al
    The novel pro-autophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous Non-Small Cell Lung Cancer.
    Int J Cancer. 2020 Jan 14. doi: 10.1002/ijc.32865.
    PubMed     Text format     Abstract available


    Int J Oncol

  22. BU M, Liu X, Liu X, Xu W, et al
    Upregulation of fascin-1 is involved in HIF-1alpha-dependent invasion and migration of hypopharyngeal squamous cell carcinoma.
    Int J Oncol. 2019;55:488-498.
    PubMed     Text format     Abstract available

  23. WANG L, Shi H, Liu Y, Zhang W, et al
    Cystathioninegammalyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Int J Oncol. 2019 Jun 6. doi: 10.3892/ijo.2019.4823.
    PubMed     Text format     Abstract available

  24. ZENG SG, Lin X, Liu JC, Zhou J, et al
    [Corrigendum] Hypoxiainduced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of nonsmall cell lung cancer via the P53/MDM2 signaling pathway.
    Int J Oncol. 2019 Dec 17. doi: 10.3892/ijo.2019.4906.
    PubMed     Text format     Abstract available


    J Clin Invest

  25. LIU M, Tong Z, Ding C, Luo F, et al
    Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
    J Clin Invest. 2020 Jan 16. pii: 131335. doi: 10.1172/JCI131335.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  26. QIU T, Zhao Y, Xuan Y, Qin Y, et al
    Robotic sleeve lobectomy for centrally located non-small cell lung cancer: A propensity score-weighted comparison with thoracoscopic and open surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 22. pii: S0022-5223(19)33072.
    PubMed     Text format     Abstract available

  27. PALEIRON N, Grassin F, Lancelin C, Tromeur C, et al
    Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study.
    J Thorac Cardiovasc Surg. 2019 Nov 23. pii: S0022-5223(19)33106.
    PubMed     Text format     Abstract available

  28. RAZI SS, Nguyen D, Villamizar N
    Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    J Thorac Cardiovasc Surg. 2019 Nov 21. pii: S0022-5223(19)33080.
    PubMed     Text format     Abstract available

  29. WHYTE RI
    Commentary: On-demand computed tomography screening for lung cancer-some surprising results.
    J Thorac Cardiovasc Surg. 2019 Dec 24. pii: S0022-5223(19)40870.
    PubMed     Text format    

  30. BRUNELLI A
    Commentary: Soft prognosticators following radical treatment of lung cancer: The time has come for a more integrated approach.
    J Thorac Cardiovasc Surg. 2019 Dec 14. pii: S0022-5223(19)37105.
    PubMed     Text format    

  31. FARROW NE, An SJ, Speicher PJ, Harpole DH Jr, et al
    Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 13. pii: S0022-5223(19)32486.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  32. CHIH-HSIN YANG J, Schuler M, Popat S, Miura S, et al
    Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Database of 693 Cases.
    J Thorac Oncol. 2020 Jan 10. pii: S1556-0864(20)30014.
    PubMed     Text format     Abstract available

  33. GUISIER F, Dubos-Arvis C, Vinas F, Doubre H, et al
    Efficacy and safety of anti-PD-1 immunotherapy in patients with advanced Non Small Cell Lung Cancer with BRAF, HER2 or MET mutation or RET-translocation. GFPC 01-2018.
    J Thorac Oncol. 2020 Jan 13. pii: S1556-0864(20)30020.
    PubMed     Text format     Abstract available

  34. LAI WV, Rudin CM
    Analyzing the Thin Tail: Searching for Biomarkers of Exceptional Survival in SCLC.
    J Thorac Oncol. 2019;14:1122-1124.
    PubMed     Text format    

  35. KOUNO S, Atagi S
    Immunotherapy for NSCLC With Brain Metastases: What Can We Learn From Real-World Data?
    J Thorac Oncol. 2019;14:1119-1121.
    PubMed     Text format    

  36. REKHTMAN N, Travis WD
    Large No More: The Journey of Pulmonary Large Cell Carcinoma from Common to Rare Entity.
    J Thorac Oncol. 2019;14:1125-1127.
    PubMed     Text format    

  37. GAY CM, Byers LA
    PARP Inhibition Combined with Immune Checkpoint Blockade in SCLC: Oasis in an Immune Desert or Mirage?
    J Thorac Oncol. 2019;14:1323-1326.
    PubMed     Text format    


    JAMA Oncol

  38. SKELIN M, Javor E, Lucijanic M
    Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer.
    JAMA Oncol. 2020 Jan 16. pii: 2758573. doi: 10.1001/jamaoncol.2019.6295.
    PubMed     Text format    

  39. SULLIVAN DR, Slatore CG
    Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer-Reply.
    JAMA Oncol. 2020 Jan 16. pii: 2758574. doi: 10.1001/jamaoncol.2019.6301.
    PubMed     Text format    


    Lung Cancer

  40. EBERT EBF, McCulloch T, Hansen KH, Linnet H, et al
    Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer.
    Lung Cancer. 2019;141:37-43.
    PubMed     Text format     Abstract available

  41. YAMASAKI M, Takenaka T, Matsumoto N, Asaoku H, et al
    Primary pulmonary collision tumor comprising squamous cell carcinoma and mucosa-associated lymphoid tissue lymphoma.
    Lung Cancer. 2019;129:107-109.
    PubMed     Text format    

  42. BUGLIONE M, Jereczek-Fossa BA, Bonu ML, Franceschini D, et al
    Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Lung Cancer. 2020;141:1-8.
    PubMed     Text format     Abstract available

  43. VAN VEGGEL B, Madeira R Santos JFV, Hashemi SMS, Paats MS, et al
    Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer.
    Lung Cancer. 2019;141:9-13.
    PubMed     Text format     Abstract available

  44. CAO X, Ganti AK, Stinchcombe T, Wong ML, et al
    Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.
    Lung Cancer. 2020;141:14-20.
    PubMed     Text format     Abstract available

  45. YOSHIMURA K, Inoue Y, Tsuchiya K, Karayama M, et al
    Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.
    Lung Cancer. 2020;141:21-31.
    PubMed     Text format     Abstract available

  46. KUBOTA K, Kunitoh H, Seto T, Shimada N, et al
    Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503.
    Lung Cancer. 2019;141:32-36.
    PubMed     Text format     Abstract available


    Oncogene

  47. MARTIN-PADRON J, Boyero L, Rodriguez MI, Andrades A, et al
    Correction: Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer.
    Oncogene. 2020 Jan 13. pii: 10.1038/s41388-019-1147.
    PubMed     Text format     Abstract available


    Oncologist

  48. BEHERA M, Steuer CE, Liu Y, Fernandez F, et al
    Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis.
    Oncologist. 2020 Jan 14. doi: 10.1634/theoncologist.2019-0661.
    PubMed     Text format     Abstract available


    PLoS One

  49. SIVIGNON M, Monnier R, Tehard B, Roze S, et al
    Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France.
    PLoS One. 2020;15:e0226196.
    PubMed     Text format     Abstract available

  50. DU Q, Baine M, Bavitz K, McAllister J, et al
    Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction.
    PLoS One. 2019;14:e0216480.
    PubMed     Text format     Abstract available

  51. TVEITARAS MK, Selheim F, Sortland K, Reed RK, et al
    Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
    PLoS One. 2019;14:e0215909.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: